These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23438958)

  • 1. Emerging anti-inflammatory therapies for atherosclerosis.
    Roubille F; Kritikou EA; Roubille C; Tardif JC
    Curr Pharm Des; 2013; 19(33):5840-9. PubMed ID: 23438958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory disorders and atherosclerosis: new therapeutic approaches.
    Charakida M; O'Neil F; Masi S; Papageorgiou N; Tousoulis D
    Curr Pharm Des; 2011 Dec; 17(37):4111-20. PubMed ID: 22204372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel targets and biomarkers for anti-atherosclerotic therapy.
    Bobryshev YV
    Curr Pharm Des; 2013; 19(33):5837-9. PubMed ID: 23438965
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
    Maranhão RC; Leite AC
    Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in imaging angiogenesis and inflammation in atherosclerosis.
    Zagorchev L; Mulligan-Kehoe MJ
    Thromb Haemost; 2011 May; 105(5):820-7. PubMed ID: 21331441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapies targeting innate immunity for fighting inflammation in atherosclerosis.
    Mendel I; Yacov N; Harats D; Breitbart E
    Curr Pharm Des; 2015; 21(9):1185-95. PubMed ID: 25312734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel directions in inflammation as a therapeutic target in atherosclerosis.
    Verweij SL; van der Valk FM; Stroes ES
    Curr Opin Lipidol; 2015 Dec; 26(6):580-5. PubMed ID: 26382552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of anti-inflammatory agents for treatment of atherosclerosis.
    Chistiakov DA; Melnichenko AA; Grechko AV; Myasoedova VA; Orekhov AN
    Exp Mol Pathol; 2018 Apr; 104(2):114-124. PubMed ID: 29378168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
    Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2016 Jeffrey M. Hoeg Award Lecture.
    Rouwet E; Lutgens E
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
    Klingenberg R; Hansson GK
    Eur Heart J; 2009 Dec; 30(23):2838-44. PubMed ID: 19880848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review.
    Zhao TX; Mallat Z
    J Am Coll Cardiol; 2019 Apr; 73(13):1691-1706. PubMed ID: 30947923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging anti-inflammatory drugs for atherosclerosis.
    Berman JP; Farkouh ME; Rosenson RS
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):193-205. PubMed ID: 23675745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of receptor-targeted systems in the battle against atherosclerosis.
    Rosas E; Sobenin I; Orekhov A; Edelman ER; Balcells M
    Curr Pharm Des; 2013; 19(33):5897-903. PubMed ID: 23438961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-based therapies for atherosclerosis.
    Ketelhuth DF; Gisterå A; Johansson DK; Hansson GK
    Curr Pharm Des; 2013; 19(33):5850-8. PubMed ID: 23438952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-inflammatory strategies in atherosclerosis.
    van der Valk FM; van Wijk DF; Stroes ES
    Curr Opin Lipidol; 2012 Dec; 23(6):532-9. PubMed ID: 23160400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and the heart - prime time for new therapeutic approaches.
    Roubille F; Tardif JC
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):259-61. PubMed ID: 23790157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism.
    Lee WR; Kim SJ; Park JH; Kim KH; Chang YC; Park YY; Lee KG; Han SM; Yeo JH; Pak SC; Park KK
    Am J Chin Med; 2010; 38(6):1077-92. PubMed ID: 21061462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.